A Converse 4-1BB and CD40 Ligand Expression Pattern Delineates Activated Regulatory T Cells (Treg) and Conventional T Cells Enabling Direct Isolation of Alloantigen-Reactive Natural Foxp3+ Treg

Natural regulatory T cells (nTreg) play a central role in the induction and maintenance of immunological tolerance. Experimental transplant models and recent clinical trials demonstrate that nTreg can control alloreactivity. To upgrade Treg-based cell therapies to a selective suppression of undesired immune reactions, only the transfer of Ag-specific nTreg represents the appropriate therapeutic option. However, Ag-specific nTreg are present at extremely low frequencies in the periphery, and so far appropriate surface markers for their precise identification are missing. In this study, we demonstrate that activated nTreg and activated conventional T cells differ in their 4-1BB and CD40 ligand (CD40L) expression signatures, allowing a clear dissection from each other. Based on the expression of 4-1BB and absence of CD40L expression, human alloantigen-reactive Foxp3+ nTreg can be directly isolated from MLR cultures with high purity. Alloantigen-reactive 4-1BB+CD40L− nTreg were characterized by a completely demethylated Treg-specific demethylated region and showed alloantigen-specific suppressive properties superior to polyclonal Treg. Importantly, isolated 4-1BB+CD40L− nTreg maintain the nTreg phenotype and alloantigen-reactivity after in vitro expansion. Our results offer the possibility to simultaneously analyze Ag-specific nTreg and conventional T cells, and to establish cellular therapies with Ag-specific nTreg aiming at a specific inhibition of unwanted immunity.

[1]  G. Hansen,et al.  CD137 deficiency does not affect development of airway inflammation or respiratory tolerance induction in murine models , 2012, Clinical and experimental immunology.

[2]  M. Betjes,et al.  Identification of Circulating Human Antigen-Reactive CD4+FOXP3+ Natural Regulatory T Cells , 2012, The Journal of Immunology.

[3]  J. Pidala,et al.  Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. , 2011, Blood.

[4]  J. Snick,et al.  Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses , 2011, Cancer Immunology, Immunotherapy.

[5]  T. Chatila,et al.  A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. , 2011, Immunity.

[6]  R. Lechler,et al.  Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells , 2011, Science Translational Medicine.

[7]  B. Falini,et al.  Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.

[8]  B. Dörken,et al.  Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study , 2011, Gene Therapy.

[9]  B. Baban,et al.  Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. , 2010, Immunity.

[10]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[11]  C. Benoist,et al.  Genomic definition of multiple ex vivo regulatory T cell subphenotypes , 2010, Proceedings of the National Academy of Sciences.

[12]  A. Ganser,et al.  Alloantigen‐specific de novo‐induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD , 2009, European journal of immunology.

[13]  A. Rudensky,et al.  Control of regulatory T cell lineage commitment and maintenance. , 2009, Immunity.

[14]  G. Illei,et al.  Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. , 2009, Blood.

[15]  M. Rossol,et al.  Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation. , 2009, Blood.

[16]  D. Niedzwiecki,et al.  Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. , 2008, Blood.

[17]  X. Wang,et al.  Agonistic Anti‐4‐1BB Antibody Promotes the Expansion of Natural Regulatory T Cells While Maintaining Foxp3 Expression , 2007, Scandinavian journal of immunology.

[18]  M. Battaglia,et al.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.

[19]  P. Greenberg,et al.  Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.

[20]  R. Selvaraj,et al.  A Kinetic and Dynamic Analysis of Foxp3 Induced in T Cells by TGF-β1 , 2007, The Journal of Immunology.

[21]  Kutlu G. Elpek,et al.  CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model1 , 2007, The Journal of Immunology.

[22]  Ernest Fraenkel,et al.  Foxp3 occupancy and regulation of key target genes during T-cell stimulation , 2007, Nature.

[23]  Edgar Schmitt,et al.  Epigenetic Control of the foxp3 Locus in Regulatory T Cells , 2007, PLoS biology.

[24]  W. Zou Regulatory T cells, tumour immunity and immunotherapy , 2006, Nature Reviews Immunology.

[25]  E. Holler,et al.  Isolation of CD4+CD25+ regulatory T cells for clinical trials. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  Andreas Thiel,et al.  Direct access to CD4+ T cells specific for defined antigens according to CD154 expression , 2005, Nature Medicine.

[27]  Mario Roederer,et al.  A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles , 2005, Nature Medicine.

[28]  H. Mcdevitt,et al.  Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice1 , 2005, The Journal of Immunology.

[29]  A. Vella,et al.  Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation. , 2005, Trends in immunology.

[30]  B. Kwon,et al.  Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB1 , 2005, The Journal of Immunology.

[31]  Aoshuang Chen,et al.  The 4-1BB Costimulation Augments the Proliferation of CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[32]  Y. Belkaid,et al.  Role for CD4+ CD25+ Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity , 2004, The Journal of experimental medicine.

[33]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[34]  J. Bae,et al.  4‐1BB‐dependent inhibition of immunosuppression by activated CD4+CD25+ T cells , 2004, Journal of leukocyte biology.

[35]  D. Klatzmann,et al.  Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State , 2003, The Journal of experimental medicine.

[36]  Anna Chodos,et al.  Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo , 2003, The Journal of experimental medicine.

[37]  Li-Sheng Lu,et al.  A T Cell-specific Enhancer of the Human CD40 Ligand Gene* , 2002, The Journal of Biological Chemistry.

[38]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[39]  Sayuri Yamazaki,et al.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.

[40]  O. Joffre,et al.  Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes , 2008, Nature Medicine.

[41]  Ramesh K Selvaraj,et al.  A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. , 2007, Journal of Immunology.

[42]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.